Therapeutic anticoagulation in critically ill patients with Covid-19–preliminary report

REMAP-CAP, ACTIV-4a, ATTACC Investigators… - MedRxiv, 2021 - medrxiv.org
Background Thrombosis may contribute to morbidity and mortality in Covid-19. We
hypothesized that therapeutic anticoagulation would improve outcomes in critically ill …
被引用次数：50 相关文章

Therapeutic Anticoagulation in Critically Ill Patients with Covid-19–Preliminary Report

R Zarychanski, ATTACC Investigators - medRxiv, 2021 - medrxiv.org
Background Thrombosis may contribute to morbidity and mortality in Covid-19. We
hypothesized that therapeutic anticoagulation would improve outcomes in critically ill …

Therapeutic Anticoagulation in Critically Ill Patients with Covid-19–Preliminary Report

R Zarychanski - 2021 - europepmc.org
Background Thrombosis may contribute to morbidity and mortality in Covid-19. We
hypothesized that therapeutic anticoagulation would improve outcomes in critically ill …